Description/REF: HEMODIALYSIS KIT: 2-LUMEN 8 FR X 11 CM/AK-11802-F; HEMODIALYSIS KIT: 2-LUMEN 12 FR X 16 CM/AK-22122; HEMODIALYSIS KIT 2L: 14 FR X 15CM AGB/AK-22142-CDC; HEMODIALYSIS KIT 2L: 14 FR X 20CM AGB/AK-25142-CDC; HEMODIALYSIS KIT: 2L 14 FR X 15 CM/ASK-22142-UMD; HEMODIALYSIS KIT: 2L 14 FR X 15 CM/ASK-22142-UNC; HEMODIALYSIS KIT: 2L 14 FR X 20 CM/ASK-25142-UMD; HEMODIALYSIS KIT 2L: 14 FR X 20 CM AGB/ASK-25142-UN1; HEMODIALYSIS KIT: 2L 14 FR X 25 CM/ASK-26142-UMD; HEMODIALYSIS KIT: 2LUMEN 12 FR X 13 CM/AU-23122-F; HEMODIALYSIS KIT: 2LUMEN 12 FR X 20 CM/AU-25122-F; HEMODIALYSIS KIT: 2L 12 FR X 16 CM AGB/CDC-22122-X1A; HEMODIALYSIS KIT: 2L 12 FR X 16 CM AGB/CDC-22122-XU1A; HEMODIALYSIS KIT: 2L 14 FR X 15 CM AGB/CDC-22142-X1A; HEMODIALYSIS KIT: 2L 12 FR X 25 CM AGB/CDC-26122-X1A; HEMODIALYSIS KIT 2L: 12 FR X 16CM AGB/AK-22122-CDC; HEMODIALYSIS KIT: 2-LUMEN 12 FR X 16 CM/AK-22122-F; HEMODIALYSIS KIT: 2-LUMEN 14 FR X 15 CM/AK-22142-F; AHDC AGB U-BEND KIT: 2-L 12 FR X 16 CM/CDC-22122-CN1AU; AHDC AGB CURVED KIT: 2-L 14 FR X 15 CM/CDC-22142-CN1AC; AHDC AGB U-BEND KIT: 2-L 12 FR X 13 CM/CDC-23122-CN1AU; AHDC AGB U-BEND KIT: 2-L 12 FR X 20 CM/CDC-25122-CN1AU; AHDC AGB CURVED KIT: 2-L 14 FR X 20 CM/CDC-25142-CN1AC;
Publicado el 24 de junio de 2026 · Inicio del retiro: 21 de abril de 2026
Resumen
FDA registra el retiro Z-2373-2026 de dispositivos médicos de Clase I, publicado el 24 de junio de 2026 e iniciado el 21 de abril de 2026. Empresa responsable: ARROW INTERNATIONAL, LLC; Estado: En curso; Cantidad reportada: 15,425; Lote: REF(Material)/UDI-DI/Lot(Batch): AK-11802-F/10801902193275, 10801902197129/33F24G0344, 33F24J0511, 33F24L0637, 33F25A0473, 33F25E0060, 33F25J0473, 33F24A0848; AK-22122/10801902193275/33F24H0232, 33F24J0523; AK-22142-CDC/10801902193275/33F24J0527, 33F24K0129, 33F24L0649, 33F25C0115, 33F25C0959, 33F25E0940, 33F25J0481, 33F25L0428, 33F24G0364; AK-25142-CDC/10801902193275, 50801902123195/33F25A0486, 33F25C0892, 33F25E0086, 33F25E0944, 33F25J0485, 33F25J0845, 33F25L0374, 33F26B0521, 33F25A0487; ASK-22142-UMD/10801902193275, 10801902136470, 10801902143690/33F25F0362, 33F25J0094, 33F26A0244, 33F26B0137, 33F24F0041; ASK-22142-UNC/10801902193275/33F25G0269, 33F24K0560; ASK-25142-UMD/10801902193275, 10801902136500/33F25B0239, 33F25E0308, 33F25G0686, 33F25K0425, 33F26A0246, 33F26C0047, 33F24K0696; ASK-25142-UN1/10801902193275, 10801902156379/33F24L1157, 33F26B0908, 33F25B0420; ASK-26142-UMD/10801902193275, 33F26A0408, 33F25B0427; AU-23122-F/10801902193275/33F25C0877, 33F25H0157, 33F24L0038; AU-25122-F/10801902193275, 70801902123328, 10801902210071/33F25G0562, 33R24L0038, 33F24D0400; CDC-22122-X1A/10801902193275, 10801902213478/33F25E0694, 33F25G0268, 33F24D0693; CDC-22122-XU1A/10801902193275, 10801902168044/33F25E0652, 33F25H0643, 33F24D0830; CDC-22142-X1A/10801902193275/33F25A0284; CDC-26122-X1A/10801902213515/33F24F1028; AK-22122-CDC/10801902193275, 10801902198492/33F24K0125, 33F24L0647, 33F25C0114, 33F25E0936, 33F25G0091, 33F24E0355; AK-22122-F/10801902193275/33F24G0360, 33F24J0524, 33F24K0126, 33F25A0482, 33F25E0075, 33F25E0937, 33F25J0839, 33F25L0413, 33F24G0361; AK-22142-F/10801902193275/33F24L0662, 33F25C0117, 33F25C0865, 33F25H0034, 33F25J0841, 33F24K0130; CDC-22122-CN1AU/10801902193275, 10801902222265/33F26A1388, 33F26B0398, 33F24L0966; CDC-22142-CN1AC/10801902193275/33F26A1550, 33F25J0455; CDC-23122-CN1AU/10801902193275, 10801902222319/33F26A0008, 33F26A1478, 33F26B0397, 33F24L0279; CDC-25122-CN1AU/10801902193275/33F25M0346, 33F25E0882; CDC-25142-CN1AC/30801902123597/36F25B0018. La Clase I indica una probabilidad razonable de consecuencias graves para la salud o muerte.
Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- ARROW INTERNATIONAL, LLC
- Distribuidor
- US Nationwide distribution including in the states of VA, NY, UT, SC, LA, MN, PA, AZ, CA, MI, OH, FL, CT, KS, IL, TX, WI, GA, NC, MD, OR, AK, NH, IA, ND, OK, NM, AL, MA, KY, WA, AR, CO, IN, ME, TN, WY, NJ, SD, MS, MO, MT, DE, ID, NE, WV, RI, VT, NV, HI, DC, PR.
- Lote
- REF(Material)/UDI-DI/Lot(Batch): AK-11802-F/10801902193275, 10801902197129/33F24G0344, 33F24J0511, 33F24L0637, 33F25A0473, 33F25E0060, 33F25J0473, 33F24A0848; AK-22122/10801902193275/33F24H0232, 33F24J0523; AK-22142-CDC/10801902193275/33F24J0527, 33F24K0129, 33F24L0649, 33F25C0115, 33F25C0959, 33F25E0940, 33F25J0481, 33F25L0428, 33F24G0364; AK-25142-CDC/10801902193275, 50801902123195/33F25A0486, 33F25C0892, 33F25E0086, 33F25E0944, 33F25J0485, 33F25J0845, 33F25L0374, 33F26B0521, 33F25A0487; ASK-22142-UMD/10801902193275, 10801902136470, 10801902143690/33F25F0362, 33F25J0094, 33F26A0244, 33F26B0137, 33F24F0041; ASK-22142-UNC/10801902193275/33F25G0269, 33F24K0560; ASK-25142-UMD/10801902193275, 10801902136500/33F25B0239, 33F25E0308, 33F25G0686, 33F25K0425, 33F26A0246, 33F26C0047, 33F24K0696; ASK-25142-UN1/10801902193275, 10801902156379/33F24L1157, 33F26B0908, 33F25B0420; ASK-26142-UMD/10801902193275, 33F26A0408, 33F25B0427; AU-23122-F/10801902193275/33F25C0877, 33F25H0157, 33F24L0038; AU-25122-F/10801902193275, 70801902123328, 10801902210071/33F25G0562, 33R24L0038, 33F24D0400; CDC-22122-X1A/10801902193275, 10801902213478/33F25E0694, 33F25G0268, 33F24D0693; CDC-22122-XU1A/10801902193275, 10801902168044/33F25E0652, 33F25H0643, 33F24D0830; CDC-22142-X1A/10801902193275/33F25A0284; CDC-26122-X1A/10801902213515/33F24F1028; AK-22122-CDC/10801902193275, 10801902198492/33F24K0125, 33F24L0647, 33F25C0114, 33F25E0936, 33F25G0091, 33F24E0355; AK-22122-F/10801902193275/33F24G0360, 33F24J0524, 33F24K0126, 33F25A0482, 33F25E0075, 33F25E0937, 33F25J0839, 33F25L0413, 33F24G0361; AK-22142-F/10801902193275/33F24L0662, 33F25C0117, 33F25C0865, 33F25H0034, 33F25J0841, 33F24K0130; CDC-22122-CN1AU/10801902193275, 10801902222265/33F26A1388, 33F26B0398, 33F24L0966; CDC-22142-CN1AC/10801902193275/33F26A1550, 33F25J0455; CDC-23122-CN1AU/10801902193275, 10801902222319/33F26A0008, 33F26A1478, 33F26B0397, 33F24L0279; CDC-25122-CN1AU/10801902193275/33F25M0346, 33F25E0882; CDC-25142-CN1AC/30801902123597/36F25B0018
- Clasificación de riesgo
- Class I
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDADescription/REF: CVC KIT: 16 GA X 8IN/AK-04210, CVC KIT: 1-L 16 GA X 8IN (20 CM)/AK-04300, CVC KIT: 14 GA X 624 de junio de 2026
- FDADescription/REF: PACING/PSI KIT: 5 FR 2L/ASK-07155-MGU24 de junio de 2026
- FDADescription/REF: HEMODIALYSIS KIT: 2L 14 FR X 20 CM AGB CDC-25142-X1A24 de junio de 2026
- FDADescription/REF: PI AGBA PICC KIT: 3L 6 FR X 40 CM W/VPS/ASK-44063-NS AGBA PICC/DELTA: 2L 5.5 FR X 5024 de junio de 2026
- FDADescription/REF: AHDC KIT: 3-L 12 FR X 16 CM/AK-12123-PCDC; AHDC KIT: 3-L 12 FR X 20 CM/AK-15123-PCDC; AHDC24 de junio de 2026
- FDADescription/REF: EPIDURAL CATHETER KIT: 19 GA X 90 CM/ASK-05502-VM1; EPIDURAL CATHETERIZATION KIT: 1924 de junio de 2026
Preguntas sobre este retiro
¿Description/REF: HEMODIALYSIS KIT: 2-LUMEN 8 FR X 11 CM/AK-11802-F; HEMODIALYSIS KIT: 2-LUMEN 12 FR X 16 CM/AK-22122; HEMODIALYSIS KIT 2L: 14 FR X 15CM AGB/AK-22142-CDC; HEMODIALYSIS KIT 2L: 14 FR X 20CM AGB/AK-25142-CDC; HEMODIALYSIS KIT: 2L 14 FR X 15 CM/ASK-22142-UMD; HEMODIALYSIS KIT: 2L 14 FR X 15 CM/ASK-22142-UNC; HEMODIALYSIS KIT: 2L 14 FR X 20 CM/ASK-25142-UMD; HEMODIALYSIS KIT 2L: 14 FR X 20 CM AGB/ASK-25142-UN1; HEMODIALYSIS KIT: 2L 14 FR X 25 CM/ASK-26142-UMD; HEMODIALYSIS KIT: 2LUMEN 12 FR X 13 CM/AU-23122-F; HEMODIALYSIS KIT: 2LUMEN 12 FR X 20 CM/AU-25122-F; HEMODIALYSIS KIT: 2L 12 FR X 16 CM AGB/CDC-22122-X1A; HEMODIALYSIS KIT: 2L 12 FR X 16 CM AGB/CDC-22122-XU1A; HEMODIALYSIS KIT: 2L 14 FR X 15 CM AGB/CDC-22142-X1A; HEMODIALYSIS KIT: 2L 12 FR X 25 CM AGB/CDC-26122-X1A; HEMODIALYSIS KIT 2L: 12 FR X 16CM AGB/AK-22122-CDC; HEMODIALYSIS KIT: 2-LUMEN 12 FR X 16 CM/AK-22122-F; HEMODIALYSIS KIT: 2-LUMEN 14 FR X 15 CM/AK-22142-F; AHDC AGB U-BEND KIT: 2-L 12 FR X 16 CM/CDC-22122-CN1AU; AHDC AGB CURVED KIT: 2-L 14 FR X 15 CM/CDC-22142-CN1AC; AHDC AGB U-BEND KIT: 2-L 12 FR X 13 CM/CDC-23122-CN1AU; AHDC AGB U-BEND KIT: 2-L 12 FR X 20 CM/CDC-25122-CN1AU; AHDC AGB CURVED KIT: 2-L 14 FR X 20 CM/CDC-25142-CN1AC; fue retirado del mercado?
Sí. FDA publicó el retiro Z-2373-2026 el 24 de junio de 2026. Peligro reportado: Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter